Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;12(6):1171-1178.
doi: 10.1002/acn3.70054. Epub 2025 Apr 14.

Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL

Affiliations

Occurrence, Risk Factors, and Prognosis of Acute Cerebral Microinfarcts in CADASIL

Xuejiao Men et al. Ann Clin Transl Neurol. 2025 Jun.

Abstract

Introduction: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic cerebral small vessel disease in adults. This study investigates the occurrence, risk factors, and prognosis of acute cerebral microinfarcts (ACMIs) in patients with CADASIL.

Methods: A total of 60 patients with genetically confirmed or pathologically verified CADASIL were enrolled in the study. ACMIs were identified as hyperintense lesions on diffusion-weighted imaging (DWI) with a diameter of less than 5 mm. The evolution of ACMIs was determined by brain MRI scans at 1 year of follow-up. Functional outcomes, cognitive performance, and quality of life after ACMIs were evaluated at months 6, 12, and 24, respectively.

Results: ACMIs were observed in 12 out of 60 patients (20%) with CADASIL and predominantly located in the white matter. Patients with CADASIL had a significantly higher risk of ACMIs when they had a patent foramen ovale (PFO) (OR, 16.429). On follow-up MRI scans at month 12, the majority of ACMIs vanished. Patients with ACMIs had worse functional outcomes, as indicated by higher mRS scores and lower MoCA scores at months 12 and 24 compared with those without ACMIs. Additionally, patients with ACMIs had significantly worse EQ-5D-3L scores at all follow-up points compared with patients without ACMIs.

Conclusions: ACMIs were not rare in patients with CADASIL. PFO could independently predict the risk of ACMIs in CADASIL. Furthermore, the majority of ACMIs can disappear at 1 year of follow-up. The findings indicate that ACMIs, influenced by PFO, are prevalent in CADASIL and associated with a decline in quality of life and functional outcomes over time.

Keywords: CADASIL; PFO; acute cerebral microinfarcts.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flow diagram of inclusion and exclusion for participants in the study.
FIGURE 2
FIGURE 2
Examples of ACMIs in patients with CADASIL. ACMIs, identified as hyperintense signals (white arrows) on DWI, were distributed in the cortical gray matter (A), deep frontal white matter (B), juxtacortical white matter (C), and posterior white matter (D). Follow‐up imagings at 1 year showed that the lesions (A, C, and D) disappeared on T2Flair (E, G, and H), whereas one ACMI (B) evolved to white matter hyperintensity (F). ACMIs, acute cerebral microinfarcts; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; DWI, diffusion‐weighted imaging.
FIGURE 3
FIGURE 3
Comparisons of the mean changes in mRS score, MoCA score, and EQ‐5D‐3L score from baseline to months 6, 12, and 24, respectively. To concretely describe disease's progression, we calculate the mean changes in the mRS score, MoCA score, and EQ‐5D‐3L score from baseline to months 6, 12, and 24, respectively. (A) There are greater changes in the mRS score from baseline to months 12 and 24 in patients with ACMIs than those without ACMIs. (B) There is no statistically significant change in the MoCA score from baseline to months 6, 12, and 24 between patients with and without ACMIs. (C) There are significantly higher changes in the EQ‐5D‐3L score from baseline to months 6, 12, and 24 in patients with ACMIs than those without ACMIs. *p < 0.05; **p < 0.01; ***p < 0.001.

Similar articles

References

    1. Guey S., Lesnik Oberstein S. A. J., Tournier‐Lasserve E., and Chabriat H., “Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management,” Stroke 52 (2021): 3025–3032. - PubMed
    1. Ghosh M., Balbi M., Hellal F., Dichgans M., Lindauer U., and Plesnila N., “Pericytes Are Involved in the Pathogenesis of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy,” Annals of Neurology 78 (2015): 887–900. - PubMed
    1. Rafalowska J., Dziewulska D., and Fidzianska A., “Cadasil: What Component of the Vessel Wall Is Really a Target for Notch 3 Gene Mutations?,” Neurological Research 26, no. 5 (2013): 558–562, 10.1179/01610425016164. - DOI - PubMed
    1. Locatelli M., Padovani A., and Pezzini A., “Pathophysiological Mechanisms and Potential Therapeutic Targets in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (Cadasil),” Frontiers in Pharmacology 11 (2020): 321. - PMC - PubMed
    1. Opherk C., Peters N., Herzog J., Luedtke R., and Dichgans M., “Long‐Term Prognosis and Causes of Death in Cadasil: A Retrospective Study in 411 Patients,” Brain 127 (2004): 2533–2539. - PubMed

LinkOut - more resources